Abstract:Endothelial dysfunction is an important risk factor for cardiovascular disease, and it represents the initial step in the pathogenesis of atherosclerosis. Failure to protect against oxidative stress-induced cellular damage accounts for endothelial dysfunction in the majority of pathophysiological conditions. Numerous antioxidant pathways are involved in cellular redox homeostasis, among which the nuclear factor-E2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1)–antioxidant response element (ARE) signaling pathway is perhaps the most prominent. Nrf2, a transcription factor with a high sensitivity to oxidative stress, binds to AREs in the nucleus and promotes the transcription of a wide variety of antioxidant genes. Nrf2 is located in the cytoskeleton, adjacent to Keap1. Keap1 acts as an adapter for cullin 3/ring-box 1-mediated ubiquitination and degradation of Nrf2, which decreases the activity of Nrf2 under physiological conditions. Oxidative stress causes Nrf2 to dissociate from Keap1 and to subsequently translocate into the nucleus, which results in its binding to ARE and the transcription of downstream target genes. Experimental evidence has established that Nrf2-driven free radical detoxification pathways are important endogenous homeostatic mechanisms that are associated with vasoprotection in the setting of aging, atherosclerosis, hypertension, ischemia, and cardiovascular diseases. The aim of the present review is to briefly summarize the mechanisms that regulate the Nrf2/Keap1–ARE signaling pathway and the latest advances in understanding how Nrf2 protects against oxidative stress-induced endothelial injuries. Further studies regarding the precise mechanisms by which Nrf2-regulated endothelial protection occurs are necessary for determining whether Nrf2 can serve as a therapeutic target in the treatment of cardiovascular diseases.

Research Progress on the Role of Keap1/Nrf2/ARE Signaling Pathway in Central Nervous System Diseases

Role of Kelch-Like Epichlorohydrin-Associated Protein 1-Nuclear Factor-E2-Related Factor 2-Antioxidant Response Element Signaling Pathway in Anti-Oxidative Stress and Its Regulators

The Role of Nrf2-ARE Signal Pathway in Tumorigenesis and Drug Resistance

Regulation of Keap1-Nrf2 signaling in health and diseases

An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases

Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases

Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease

Advances in Study on Nrf2/ARE Signal Pathway and Its Relevant Drugs

The role of Nrf2 in oxidative stress-induced endothelial injuries

The role of Keap1-Nrf2 signaling pathway in the treatment of respiratory diseases and the research progress on targeted drugs

Role of Nrf2-ARE Pathway in Oxidative Stress Injury and Its Relationship with Other Signaling Pathways

Nrf2/Keap1/ARE signaling: Towards specific regulation

Research progress in epigenetic regulation of Keap1-Nrf2 signal pathway

Research progress on Nrf2-ARE signaling pathway involved in liver disease pathological mechanism

Post-translational modifications of Keap1: the state of the art

Role of Nrf2in neuroprotection and its mechanisms

Progress on Antioxidant Transcription Factor-Nrf2

Nrf2 Signaling Pathway: Pivotal Roles in Inflammation.

Epigenetic Regulation of Keap1-Nrf2 Signaling

Keap1‐Nrf2 signaling pathway in angiogenesis and vascular diseases